IF YOU DO NOT THINK YOU CAN HELP REDUCE THE EFFECTS OF ADVERSE DRUG REACTION THINK AGAIN. IF YOU KNOW ANYONE WORKING WITH THE MEDICAL COMMUNITY, DOCTORS, NURSES, NURSING HOME OWNERS, MEDICAL SUPPLY BUSINESS OWNERS, PHYSICIANS ASSISTANTS, PHARMACEUTICAL SALES REPS ETC. YOU WILL BE HELPING REDUCE THE EFFECTS OF ADVERSE DRUG REACTION BY REFERRING THEM TO PARTICIPATE IN OUR PROGRAM.
BELOW IS A LETTER YOU CAN GIVE TO YOUR DOCTOR TO LET HIM KNOW YOU WANT THE PHARMACOGENETIC DNA TEST (PGT).
Dear Dr (put your doctors name here),
Your patient, (put your name here) is requesting a Pharmacogenetic DNA Test, as a result of receiving information about its benefits. Pharmacogenetic tests can provide you with any genetic factors that might adversely interact with current or future drugs prescribed that may adversely affect me. As you well know, the more drugs the patient takes the more risk of adverse drug reaction.
Medicare covers this test with no deductible or co-pay and many insurance companies cover it as well, subject to their policy deductible and copay.
The test only requires a buccal swab. There is a prepaid, overnight, FedEx envelope to send the specimen to the Lab. Once submitted, you will receive a comprehensive PharmD report with my test results. You will find this to be a comprehensive and yet simple report.
I would like you to make an appointment with a Certified Representative to discuss the test procedure and simplicity of activating this greatly needed test within your practice.
Pharmacogenetic Testing (PGT) Pharmacogenetics can show how a person’s genetic makeup affects the metabolism of medications. Pharmacogenetic testing (PGT) detects normal and single nucleotide polymorphism (SNPs) in the alleles of genes and their associated enzymes. PGT results therefore predict a person’s ability to metabolize certain medications. We currently provide testing services on a total of nine genes (CYP2C9, CYP2C19, CYP2D6, CYP3A4, CYP3A5, Factor II, Factor V Leiden, MTHFR, and VKORC1) to give physicians a broad scope of information.
Cytochrome P450 enzymes (CYPs) include a superfamily of 57 enzymes. Subfamilies 1-‐3 are responsible for 75% of all drug metabolism. PGT results on the CYP genes are reported as extensive metabolizers (EM), poor metabolizers (PM), intermediate metabolizers (IM), or ultra-‐rapid metabolizers (UM) for their varying degrees of drug metabolizing abilities. Extensive metabolizers have normal drug metabolism. Poor metabolizers have no or very low metabolism; intermediate metabolizers have reduced metabolism; and ultra-‐rapid metabolizers have higher-‐than-‐normal drug metabolism.
Pharmacogenetic testing can be particularly useful in:
Chronic pain management
Knowing a patient’s genotypes prior to prescribing pain and other medicine
Minimizing debilitating side effects
PGT testing can mean the difference between a treatment failure and a successful outcome.
You will know the following critical information for your patients:
Which medication will BEST work for your patients
Which medication will NOT work for your patients.
“The right information – right drug – right dosage – right from the beginning”
Contact: Albert Bresciani 352-250-4412 [email protected]
Dear Dr (put your doctors name here),
Your patient, (put your name here) is requesting a Pharmacogenetic DNA Test, as a result of receiving information about its benefits. Pharmacogenetic tests can provide you with any genetic factors that might adversely interact with current or future drugs prescribed that may adversely affect me. As you well know, the more drugs the patient takes the more risk of adverse drug reaction.
Medicare covers this test with no deductible or co-pay and many insurance companies cover it as well, subject to their policy deductible and copay.
The test only requires a buccal swab. There is a prepaid, overnight, FedEx envelope to send the specimen to the Lab. Once submitted, you will receive a comprehensive PharmD report with my test results. You will find this to be a comprehensive and yet simple report.
I would like you to make an appointment with a Certified Representative to discuss the test procedure and simplicity of activating this greatly needed test within your practice.
Pharmacogenetic Testing (PGT) Pharmacogenetics can show how a person’s genetic makeup affects the metabolism of medications. Pharmacogenetic testing (PGT) detects normal and single nucleotide polymorphism (SNPs) in the alleles of genes and their associated enzymes. PGT results therefore predict a person’s ability to metabolize certain medications. We currently provide testing services on a total of nine genes (CYP2C9, CYP2C19, CYP2D6, CYP3A4, CYP3A5, Factor II, Factor V Leiden, MTHFR, and VKORC1) to give physicians a broad scope of information.
Cytochrome P450 enzymes (CYPs) include a superfamily of 57 enzymes. Subfamilies 1-‐3 are responsible for 75% of all drug metabolism. PGT results on the CYP genes are reported as extensive metabolizers (EM), poor metabolizers (PM), intermediate metabolizers (IM), or ultra-‐rapid metabolizers (UM) for their varying degrees of drug metabolizing abilities. Extensive metabolizers have normal drug metabolism. Poor metabolizers have no or very low metabolism; intermediate metabolizers have reduced metabolism; and ultra-‐rapid metabolizers have higher-‐than-‐normal drug metabolism.
Pharmacogenetic testing can be particularly useful in:
Chronic pain management
Knowing a patient’s genotypes prior to prescribing pain and other medicine
Minimizing debilitating side effects
PGT testing can mean the difference between a treatment failure and a successful outcome.
You will know the following critical information for your patients:
Which medication will BEST work for your patients
Which medication will NOT work for your patients.
“The right information – right drug – right dosage – right from the beginning”
Contact: Albert Bresciani 352-250-4412 [email protected]